- Solutions Overview
- Clinical Development
- Outsourcing Services
- Parexel® Biotech
- Medical Affairs
- Real-World Evidence and Late Phase
- Our Company
- Management Team
- Diversity, Equity and Inclusion
- Career Opportunities
- Trust & Privacy
A lot of moving parts go into Phase II and III clinical trials. That’s why we give you the guidance to streamline the fine details of clinical development. Our world-class management teams help eliminate delays by leading the way from recruitment strategies, medical writing, and clinical logistics, all the way through the regulatory process.
Our eClinical technologies keep you connected at every stage, no matter where in the world your studies run. And with communities of patients across continents, we help save time looking for volunteers who are the right fit. Because no matter how complex your study, we’re here to help you stay on top of it all.
Your clinical development has shown strong potential so far and the end goal of launching to market inches closer. As you enter Phases IIb and III, enhanced scrutiny of your fledgling product will inevitably throw up various challenges.
This is the time when your decision to partner with us proves most fruitful, as our experienced consultants dig deep into their extensive knowledge and deploy the resources that fit your needs – sharp strategies to steady the course, clinical logistics to implement trials swiftly and the regulatory knowledge to avoid the obstacles which could lead to extra risks, delays, and costs.
Because our Regulatory & Access experts are plugged into the realities of clinical development, their technical insights – regulatory, pricing and reimbursement, patient access – are geared towards more practical, actionable solutions that can be integrated into your Parexel development programs. It’s the difference between ideas that are nice in theory, and those that are effective in practice.
No matter what this phase throws at you, we’ll be at your side, as invested in and excited by your potential new treatment as you are.
Operationalizing Cell and Gene Therapy Trials
Putting AI to Work in Your Safety Program
The Rise of FSP Outsourcing
Embarking on the Next Era of Precision Medicine
Top Ten Rules for Success in DCTs
Innovating for the future of drug development
Innovating for the Future of Drug Development
Making rare disease drug development personal
Entering a new age of evidence generation: synthetic control models
The science of ethnobridging
Decentralized clinical trials - A more patient-centric approach
COVID-19 The Great Decentralized Clinical Trials Accelerator
PharmaVOICE RWE Showcase -The RWE Evolution
Bringing clinical trials to patients with the decentralized model
Real-world evidence for more efficient, patient-focused trials
How to Accelerate Oncology Clinical Trials through Site Relationships and Patient Insights
The FSP Workforce of the Future: Spotlight on CRAs
We are always available for a conversation.